Douglas C Palmer

I am devoted to innovating and translating novel immunotherapies for the treatment of metastatic cancer. At the NCI, I spent over 19 years working for Immunotherapy pioneers Nick Restifo and Steven Rosenberg trying to uncover the fundamentals of Immuno-Oncology. Now as the Executive Director of Immuno-Oncology at AstraZeneca under the tutelage of Cancer Biology guru Carl Barrett, I am making immunotherapies for cancer patients a reality.